NeuBase Therapeutics - 53 Year Dividend History | NBSE
Historical dividend payout and yield for NeuBase Therapeutics (NBSE) since 1971. The current TTM dividend payout for NeuBase Therapeutics (NBSE) as of May 08, 2024 is $0.00. The current dividend yield for NeuBase Therapeutics as of May 08, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.002B |
$0.000B |
|
NeuBase Therapeutics Inc. is a biotechnology company. It is engaged in developing antisense therapies to address genetic diseases. The company's proprietary platform includes PATrOL(TM). NeuBase Therapeutics Inc., formerly known as Ohr Pharmaceutical Inc., is based in Pittsburgh, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
